Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rMenB Vaccine Lot Consistency and Safety in Infants
NCT00657709Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2008
- Primary completion
- Jan 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 5
01
Overview
A Phase 3 trial of recombinant neisseria meningitidis group B nhba fusion protein in meningococcal meningitis, sponsored by Novartis. Started Mar 2008; status: completed.
02
Drugs
recombinant neisseria meningitidis group B nhba fusion protein
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT00657709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657709.